Please Wait
Applying Filters...
menu
    • menu
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Meningococcal Polysaccharide Vaccine Group C

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Pfizer Canada ULC

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Pfizer Canada ULC

    MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y, TETANUS TOXOID
    arrow
    BePharma
    Not Confirmed

    Pfizer Canada ULC

    U.S.A
    arrow
    BePharma
    Not Confirmed

    Patent Expiration Date : 2026-06-23

    Date Granted : 2015-05-05

    MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y, TETANUS TOXOID

    Brand Name : NIMENRIX

    Patent Number : 2611960

    Filing Date : 2006-06-23

    Strength per Unit : (0.5mL) 5 mcg / 5 mcg / 5 mcg / 5 mcg / 44 mcg

    Dosage Form : POWDER FOR SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAMUSCULAR

    Patent Expiration Date : 2026-06-23

    Date Granted : 2015-05-05

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Pfizer Canada ULC

    MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y, TETANUS TOXOID
    arrow
    BePharma
    Not Confirmed

    Pfizer Canada ULC

    U.S.A
    arrow
    BePharma
    Not Confirmed

    Patent Expiration Date : 2026-06-23

    Date Granted : 2016-10-18

    MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y, TETANUS TOXOID

    Brand Name : NIMENRIX

    Patent Number : 2612963

    Filing Date : 2006-06-23

    Strength per Unit : (0.5mL) 5 mcg / 5 mcg / 5 mcg / 5 mcg / 44 mcg

    Dosage Form : POWDER FOR SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAMUSCULAR

    Patent Expiration Date : 2026-06-23

    Date Granted : 2016-10-18

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Pfizer Canada ULC

    MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y, TETANUS TOXOID
    arrow
    BePharma
    Not Confirmed

    Pfizer Canada ULC

    Country
    arrow
    BePharma
    Not Confirmed

    Patent Expiration Date : 2025-04-29

    Date Granted : 2020-01-14

    MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y, TETANUS TOXOID

    Brand Name : NIMENRIX

    Patent Number : 2564366

    Filing Date : 2005-04-29

    Strength per Unit : (0.5mL) 5 mcg / 5 mcg / 5 mcg / 5 mcg / 44 mcg

    Dosage Form : POWDER FOR SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAMUSCULAR

    Patent Expiration Date : 2025-04-29

    Date Granted : 2020-01-14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Pfizer Canada ULC

    MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y, TETANUS TOXOID
    arrow
    BePharma
    Not Confirmed

    Pfizer Canada ULC

    Country
    arrow
    BePharma
    Not Confirmed

    Patent Expiration Date : 2034-03-17

    Date Granted : 2023-09-05

    MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135, MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y, TETANUS TOXOID

    Brand Name : NIMENRIX

    Patent Number : 2903322

    Filing Date : 2014-03-17

    Strength per Unit : (0.5mL) 5 mcg / 5 mcg / 5 mcg / 5 mcg / 44 mcg

    Dosage Form : POWDER FOR SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAMUSCULAR

    Patent Expiration Date : 2034-03-17

    Date Granted : 2023-09-05

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.